- Home
- RVPH vs SWVL Comparison
RVPH vs SWVL Comparison
Compare RVPH & SWVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- SWVL
- Stock Information
- Founded
- RVPH 2006
- SWVL 2017
- Country
- RVPH United States
- SWVL United Arab Emirates
- Employees
- RVPH N/A
- SWVL N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- SWVL Business Services
- Sector
- RVPH Health Care
- SWVL Consumer Discretionary
- Exchange
- RVPH Nasdaq
- SWVL Nasdaq
- Market Cap
- RVPH 50.0M
- SWVL 54.8M
- IPO Year
- RVPH N/A
- SWVL N/A
- Fundamental
- Price
- RVPH $1.78
- SWVL $6.32
- Analyst Decision
- RVPH Strong Buy
- SWVL
- Analyst Count
- RVPH 4
- SWVL 0
- Target Price
- RVPH $15.33
- SWVL N/A
- AVG Volume (30 Days)
- RVPH 5.1M
- SWVL 28.1K
- Earning Date
- RVPH 11-14-2024
- SWVL 01-07-2025
- Dividend Yield
- RVPH N/A
- SWVL N/A
- EPS Growth
- RVPH N/A
- SWVL N/A
- EPS
- RVPH N/A
- SWVL 0.27
- Revenue
- RVPH N/A
- SWVL $22,852,263.00
- Revenue This Year
- RVPH N/A
- SWVL $1,728.00
- Revenue Next Year
- RVPH N/A
- SWVL N/A
- P/E Ratio
- RVPH N/A
- SWVL $17.32
- Revenue Growth
- RVPH N/A
- SWVL N/A
- 52 Week Low
- RVPH $0.60
- SWVL $0.95
- 52 Week High
- RVPH $5.67
- SWVL $21.94
- Technical
- Relative Strength Index (RSI)
- RVPH 53.02
- SWVL 56.25
- Support Level
- RVPH $1.23
- SWVL $6.13
- Resistance Level
- RVPH $1.75
- SWVL $6.75
- Average True Range (ATR)
- RVPH 0.53
- SWVL 0.45
- MACD
- RVPH -0.07
- SWVL -0.10
- Stochastic Oscillator
- RVPH 18.57
- SWVL 26.67
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About SWVL Swvl Holdings Corp
Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. Its technology and services provide commuters, travelers and businesses with an alternative to traditional public transportation, taxi companies or other ridesharing companies. The company's core product is B2C Swvl Retail offering, which provides riders with a network of minibuses and other vehicles running on fixed or semi-fixed routes within cities. Commuters use its Swvl mobile application to book rides between pre-defined pick-up points located throughout the city.